摘要
目的调查医院高值抗癌药的使用情况,了解本地区恶性肿瘤流行趋势,提高居民癌症防控知识的知晓率、癌症筛查参与率。方法采用回顾性分析法,收集东港市中心医院2018年8月至2019年8月申请高值抗癌药的品种、审批例数、销售金额。结果2018年8月至2019年8月获批124例患者高值抗癌药品审批表,共涉及到22种抗癌药,销售金额为306.04万元,曲妥珠单抗注射液、吉非替尼片、利妥昔单抗注射液用药金额占高值抗癌药金额的前3名,占总金额50.81%。肺癌、乳腺癌、淋巴瘤是本地区高发肿瘤;城镇居民医疗保险审批数占51.61%,新型农村合作医疗占48.39%;女性患者占58.87%,男性占41.13%。结论医院高值抗癌药抗用药情况与目前我国肿瘤发病率及治疗趋势基本一致,结合高值抗癌药申请结果,可制定相应的防控措施,为临床诊疗提供依据。
Objective To investigate the use of high-value anticancer drugs in hospital,to understand the epidemic trend of malignant tumors in the region,and to improve the awareness rate of cancer prevention and treatment knowledge of residents and the participation rate of cancer screening.Methods The varieties,approval cases and sales amount of high-value anticancer drugs applied by Dong Gang Central Hospital from August 2018 to August 8,2019 were collected,with the method of retrospective analysis.Results From August 2018 to August 2019,a total of 124 patients of high value anti-cancer drug approval were obtained,involving 22 kinds of anticancer drugs.Total amount was 3.0604 million yuan.The amount of trastuzumab injection,gefitinib tablets,and rituximab injection accounted for the top 3 high-value anticancer drugs,accounting for 50.81%of the total amount.Lung cancer,breast cancer,and lymphoma were the most common tumors in this region;the number of medical insurance approvals for urban residents accounted for 51.61%,the new rural cooperative medical system accounted for 48.39%;female patients accounted for 58.87%,and men accounted for 41.13%.Conclusion The anti-drug resistance of high value anticancer drugs in a hospital is basically consistent with the current tumor incidence rate and treatment trend in China.We can combine with the application results of high value anticancer drugs to formulate corresponding prevention and control measures and to provide basis for clinical diagnosis and treatment.
作者
邓琳
DENG Lin(Dong Gang Central Hospital,Donggang 118300,China)
出处
《中国药物经济学》
2020年第8期74-78,共5页
China Journal of Pharmaceutical Economics
关键词
高值抗癌药
恶性肿瘤
防控
High value anticancer drugs
Malignant tumor
Prevention and treatment
